Proactive One2One Biotech Forum
Past event
Date
30 July 2020
Oncimmune CEO, Dr Adam M Hill presents progress on the Company's three year strategy.
We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum.
Dr Adam M Hill, CEO
Related:
News
02 Mar 2020
News—02 Mar 2020